Valmark Advisers Inc. Has $2.24 Million Holdings in Quanterix Co. (NASDAQ:QTRX)

Valmark Advisers Inc. raised its holdings in shares of Quanterix Co. (NASDAQ:QTRX) by 88.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 210,878 shares of the company’s stock after buying an additional 98,883 shares during the quarter. Valmark Advisers Inc.’s holdings in Quanterix were worth $2,242,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of QTRX. SG Americas Securities LLC acquired a new position in shares of Quanterix during the third quarter worth approximately $139,000. nVerses Capital LLC acquired a new position in shares of Quanterix during the third quarter worth approximately $60,000. abrdn plc lifted its holdings in shares of Quanterix by 163.6% during the third quarter. abrdn plc now owns 166,398 shares of the company’s stock worth $2,157,000 after buying an additional 103,281 shares during the last quarter. Janney Capital Management LLC raised its stake in shares of Quanterix by 33.6% in the third quarter. Janney Capital Management LLC now owns 23,553 shares of the company’s stock valued at $305,000 after purchasing an additional 5,930 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust raised its stake in shares of Quanterix by 0.8% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock valued at $7,300,000 after purchasing an additional 4,406 shares in the last quarter. 86.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, TD Cowen upped their target price on Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research note on Wednesday, November 13th.

Quanterix Trading Down 0.1 %

Shares of NASDAQ QTRX opened at $8.05 on Monday. The business has a fifty day simple moving average of $9.96 and a 200 day simple moving average of $11.74. The firm has a market capitalization of $310.09 million, a price-to-earnings ratio of -7.59 and a beta of 1.33. Quanterix Co. has a one year low of $7.49 and a one year high of $29.70.

Quanterix (NASDAQ:QTRX) last announced its quarterly earnings results on Monday, December 23rd. The company reported ($0.22) earnings per share for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. On average, research analysts anticipate that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.